111, Inc. (YI)
Nasdaq · Healthcare · Medical Distribution
$3.15−2.17%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $27.7M
- P/E (trailing)
- 0.3
- Forward P/E
- 22.5
- 52-week range
- $2.48 – $11.17
- 52-week change
- −31.63%
- EPS (trailing)
- $10.49
Fiscal year to Dec 2025
- Revenue
- $1.8B (−9.00%)
- Operating margin
- 0.0%
- Diluted EPS
- −$0.05
- Free cash flow
- $16.4M
From the company’s annual report on SEC EDGAR.
About 111, Inc.
111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company offers supply chain integration services that help pharmaceutical companies manage products through online and offline channels; product promotion, customer analytics, patient education, and brand awareness services; and marketing and channel data services. It also provides 1 Pharmacy online wholesale pharmacy that offers pharmaceutical and other health and wellness products; and 1 Medicine Marketplace online retail pharmacy that provides drugs, nutritional supplements, medical supplies and devices, personal care, and baby products. In addition, the company offers online loan application services; cloud-based inventory management services; smart procurement services, which collect pharmacies' historical purchase orders and inventory data; and Hawkeye automated salesforce tool, as well as online consultation, e-prescription, and data services.
Headquarters: Shanghai, China · 1,063 employees · corporate.111.com.cn